Free Trial

Anpario (LON:ANP) Share Price Crosses Below 200-Day Moving Average - Here's Why

Anpario logo with Consumer Defensive background

Key Points

  • Anpario plc's stock price fell below its 200-day moving average during trading, reaching a low of GBX 371.25 ($4.93) while the latest trading price was GBX 381.50 ($5.06).
  • The company has a market capitalization of £65.09 million and a low debt-to-equity ratio of 0.10.
  • Anpario specializes in natural feed additives for animal health and nutrition, offering a range of products designed to support animal gut health and feed quality.
  • MarketBeat previews top five stocks to own in September.

Anpario plc (LON:ANP - Get Free Report)'s stock price passed below its two hundred day moving average during trading on Friday . The stock has a two hundred day moving average of GBX 420.40 ($5.58) and traded as low as GBX 371.25 ($4.93). Anpario shares last traded at GBX 381.50 ($5.06), with a volume of 30,619 shares trading hands.

Anpario Price Performance

The business's 50 day moving average is GBX 414.78 and its 200-day moving average is GBX 420.40. The firm has a market capitalization of £65.09 million, a P/E ratio of 21.07 and a beta of 0.58. The company has a quick ratio of 5.16, a current ratio of 6.15 and a debt-to-equity ratio of 0.10.

Anpario Company Profile

(Get Free Report)

Anpario plc, together with its subsidiaries, engages in the production and distribution of natural feed additives for animal health, hygiene, and nutrition. Its health and performance category offers various products that support and maintain animal gut health, such as phytogenic and acid based eubiotics, and omega fatty acids under the Orego-Stim, Optomega, pHorce, Salkil, and Genex brands; feed quality category provides products, such as enzymes, antioxidants, pellet binders, mould inhibitors, and acid based eubiotics under the pHorce, Feedzyme, Salgard, Oxigard, Moldgard, and Mastercube brands.

See Also

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Anpario Right Now?

Before you consider Anpario, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Anpario wasn't on the list.

While Anpario currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

3 Value Plays Set to Explode
5 Stocks to BUY NOW in August 2025
The $2.5B Merger No One Is Talking About

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines